“The acquisition further expands our scleral lens portfolio, extending the way we help improve the way people see each day,” said Juan Carlos Aragón, President of CooperVision’s Specialty EyeCare Division. “Its innovative products, services, technologies and people will augment what we are building with Paragon, Procornea, and Soflex. This creates even more opportunities for CooperVision to partner with eye care professionals (ECPs), and for them to meet a range of patient needs.”
Blanchard, with its network of distributors, enjoys a particularly strong brand position in North America, Europe (including Scandinavia), Central America and South America. Its recently introduced OneFit™ MED scleral lens is being rapidly adopted by ECPs, and the company has grown globally over the past several years, with its products available in more than 20 countries.
“The new relationship with CooperVision will be instrumental in extending our reach and potential, providing access to a broad range of research, operations and commercial resources for the benefit of customers and wearers,” said Jean Blanchard, President of Blanchard Contact Lenses, who will continue to lead the organization. He has also been appointed as a member of the CooperVision Specialty EyeCare global management team.
Founded in 1986, Blanchard has operations in Sherbrooke, Quebec, Canada and Manchester, New Hampshire, United States, and employs approximately 70 people. Like CooperVision’s other specialty businesses, it will retain its name and continue to operate as a separate yet complementary organization. Customers should continue to work with their current representatives.
The acquisition includes Blanchard’s U.S. and Canadian entities.
# # #
CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit coopervision.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, Calif., Cooper has more than 12,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Mike McDougall, APR, Fellow PRSA
McDougall Communications for CooperVision, Inc.
email@example.com or +1-585-545-1815